Novel biomarkers of overactive bladder syndrome
نویسندگان
چکیده
منابع مشابه
Biomarkers in the Overactive Bladder Syndrome
Overactive bladder (OAB) is a symptomatic complex affecting both men and women. The overall incidence is above 10% but may exceed 40% in the elderly population (Irwin et al., 2006; Irwin et al., 2009; Sexton et al., 2009a). OAB is defined by the International Continence Society (ICS) as a clinical syndrome characterized by urinary urgency, with or without incontinence, usually with frequency an...
متن کاملA novel approach to overactive bladder syndrome treatment
Overactive bladder (OAB) symptoms are among the most bothersome complaints of our elderly patients. They have substantial impact on all aspects of pa-tients' well–being and reduce their quality of life. This condition affects almost 12% of the adult population of Europe. The prevalence is constantly rising with age and reaches 36% in the group of patients above 75 years of age. The incidence of...
متن کاملThe management of overactive bladder syndrome.
Serge P Marinkovic director of urology and female pelvic medicine and reconstructive surgery , Eric S Rovner professor of urology , Robert M Moldwin associate professor of clinical urology, director of the Interstitial Cystitis Center , Stuart L Stanton professor emeritus of urogynaecology , Lisa M Gillen independent researcher and writer , Christina MMarinkovic clinical director of nursing ser...
متن کاملOveractive bladder syndrome - management and treatment options.
BACKGROUND Overactive bladder syndrome is a symptom-based clinical diagnosis. It is characterised by urinary urgency, frequency and nocturia, with or without urge urinary incontinence. These symptoms can often be managed in the primary care setting. OBJECTIVE This article provides a review on overactive bladder syndrome and provides advice on management for the general practitioner. DISCUSS...
متن کاملOveractive bladder syndrome pharmacotherapy: future treatment options
Overactive bladder syndrome (OAB) is a lifestyle disease and its incidence increases with age. Although it is not a life-threatening disease, it is known to have a significant impact on the quality of life. The first-choice pharmacological treatment of OAB is antimuscarinics. However, their limited clinical effectiveness and unsatisfactory tolerance profile, combined with the advancement of kno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ginekologia Polska
سال: 2017
ISSN: 2543-6767,0017-0011
DOI: 10.5603/gp.a2017.0102